BIOMAT Database Logo BIOMAT Database Logo

Sulphasalazine-induced agranulocytosis successfully treated with filgrastim. 1996

G P Crawford, and B L Laurence

UI MeSH Term Description Entries
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069585 Filgrastim A recombinant granulocyte colony-stimulating factor (G-CSF) that is used in the treatment and prevention of NEUTROPENIA, preparation and collection of blood progenitor cells, and for use in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION. Filgrastim-sndz,G-CSF Recombinant, Human Methionyl,Granix,Neupogen,R-metHuG-CSF,Recombinant-Methionyl Human Granulocyte Colony-Stimulating Factor,Tbo-Filgrastim,Topneuter,Zarxio,G CSF Recombinant, Human Methionyl,R metHuG CSF,Recombinant Methionyl Human Granulocyte Colony Stimulating Factor,Tbo Filgrastim
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D012460 Sulfasalazine A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) Salicylazosulfapyridine,Asulfidine,Azulfadine,Azulfidine,Azulfidine EN,Colo-Pleon,Pleon,Pyralin EN,Salazopyrin,Salazosulfapyridine,Sulfasalazin medac,Sulfasalazin-Heyl,Sulfasalazine FNA,Sulphasalazine,Ucine,Ulcol,ratio-Sulfasalazine,Colo Pleon,Sulfasalazin Heyl,ratio Sulfasalazine
D016179 Granulocyte Colony-Stimulating Factor A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines. Colony-Stimulating Factor, Granulocyte,G-CSF,Myeloid Growth Factor,Colony Stimulating Factor, Granulocyte,Factor, Granulocyte Colony-Stimulating,Factor, Myeloid Growth,Granulocyte Colony Stimulating Factor,Growth Factor, Myeloid

Related Publications

G P Crawford, and B L Laurence
Sulphasalazine induced agranulocytosis.
July 1983, The New Zealand medical journal,
G P Crawford, and B L Laurence
Sulphasalazine induced agranulocytosis revisited.
December 1998, Irish medical journal,
G P Crawford, and B L Laurence
Agranulocytosis successfully treated with ACTH.
June 1952, British medical journal,
G P Crawford, and B L Laurence
Immunologic mechanism in sulphasalazine-induced agranulocytosis.
January 1990, Acta haematologica,
G P Crawford, and B L Laurence
Agranulocytosis associated with sulphasalazine therapy.
September 1973, Postgraduate medical journal,
G P Crawford, and B L Laurence
Sulphasalazine induced agranulocytosis in a patient with rheumatoid arthritis.
June 1990, Irish journal of medical science,
G P Crawford, and B L Laurence
Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
June 1995, The Journal of clinical psychiatry,
G P Crawford, and B L Laurence
Filgrastim for low-dose, captopril-induced agranulocytosis.
July 1993, Lancet (London, England),
G P Crawford, and B L Laurence
[Case of agranulocytosis successfully treated with pentose nucleotide].
September 1954, Polski tygodnik lekarski,
G P Crawford, and B L Laurence
Agranulocytosis associated with sulphasalazine ('Salazopyrin') therapy.
June 1963, Lancet (London, England),
Copied contents to your clipboard!